Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a bone drug boost spine surgery success? new trial aims to find out

NCT ID NCT06973109

First seen Nov 15, 2025 · Last updated May 25, 2026 · Updated 30 times

Summary

This study tests if romosozumab (Evenity), a monthly injection, can improve bone density and muscle mass better than a weekly pill (alendronate) in postmenopausal women with osteoporosis who need spine surgery. About 36 women will be randomly assigned to one of the two treatments and followed for a year with scans and questionnaires. The goal is to see if stronger bones and muscles lead to fewer surgery complications and better recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS, POST-MENOPAUSAL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Pittsburgh Medical Center (UPMC) - Presbyterian Hospital

    Pittsburgh, Pennsylvania, 15213, United States

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.